AVIOR, INC.

Cary, NC · Medtech · Still private

Antiviral coating applied to PPE masks using ultrasonic spray technology to reduce pathogen transmission

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · aviorx.com

Sector: Medtech
Headquarters: Cary, NC
Total capital: $556K

Federal grants: $556K; 2 awards · 2019–2021; Rank in peer group#11 of 35
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 3; 8 pending · first 2022; Rank in peer group#6 of 35

Capital timeline

Latest events

Jul 2021Federal grantNSF · Phase I · SBIR Phase I: A Safe and Effective Copper Nanoparticle Suspension Formulation for Face Mask Applications against SARS-COV-2 and Other Viruses (COVID-19)$256K
Mar 2019Federal grantHealth and Human S · Phase I · A Novel Fast Acting Nalmefene Formulation for the Prevention and Treatment of Opioid Overdose$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 35 peers

Line = median

Medtech · Material

Federal grants#11 · top 31%
Granted patents#6 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 11

Jun 2, 2026GrantedMethod And Device Of Treating Chronic Kidney Disease-associated PruritusUSPTOUS 12,642,796
Nov 22, 2022GrantedTransmucosal Film Composition And Methods Of Making And Using The SameUSPTOUS 11,504,342
May 3, 2022GrantedPharmaceutical Active-containing Film Delivery Device For Oral Transmucosal AdministrationUSPTOUS 11,318,107

Show all 11 patent records

Method And Device Of Treating Chronic Kidney Disease-associated PruritusJun 2, 2026 · US 12,642,796Granted
Transmucosal Film Composition And Methods Of Making And Using The SameNov 22, 2022 · US 11,504,342Granted
Pharmaceutical Active-containing Film Delivery Device For Oral Transmucosal AdministrationMay 3, 2022 · US 11,318,107Granted
Method And Device Of Treating Chronic Kidney Disease-associated PruritusApplication PCTUS2019056635Pending
Transmucosal Film Composition And Methods Of Making And Using The SameApplication 62890346Pending
Transmucosal Film Composition And Methods Of Making And Using The SameApplication PCTUS2019019150Pending
Method And Device Of Treating Chronic Kidney Disease-associated PruritusApplication 62747506Pending
Use Of Nalmefene Hydrochloride Buccal Films In Treating Liver Disease Associated PruritusApplication PCTUS2025031191Pending
Transmucosal Film Composition And Methods Of Making And Using The SameApplication 62633907Pending
Use Of Nalmefene Hydrochloride Buccal Films In Treating Liver Disease Associated PruritusApplication 63766193Pending
Use Of Nalmefene Hydrochloride Buccal Films In Treating Liver Disease Associated PruritisApplication 63652369Pending

Neural Dynamics Technologies LLCSimilar federal contract value in Medtech · null in contracts
ALLEVIATE SOLUTIONS INCSimilar federal contract value in Medtech · null in contracts
SIMPLUSDX, INC.Similar federal contract value in Medtech · null in contracts
CROSSLINER INCSimilar federal contract value in Medtech · null in contracts
Deurion R&D LLCSimilar federal contract value in Medtech · null in contracts
RESPAIR, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.